Aura Biosciences, Inc. (AURA) stock analysis

In our weekly check, Aura Biosciences, Inc. is graded F (A to F). Of 18 checks on debt, profit, cash flow and trend: 5 pass, warnings: 3, red flags: 10.

About Aura Biosciences, Inc.

Aura Biosciences, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as AURA.

What our checks show for AURA

Red flags

Warning signs

Strengths

Similar companies

ALMS · SLDB · KURA · PRME · ARDX · NVCT

Questions

What grade does Aura Biosciences, Inc. (AURA) have?

In our weekly check, Aura Biosciences, Inc. is graded F (A to F). Of 18 checks on debt, profit, cash flow and trend: 5 pass, warnings: 3, red flags: 10. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of AURA stock?

This week's biggest flags for Aura Biosciences, Inc.: Weak EPS forecast, Margins expected to shrink, Weak EPS growth. In total 13 of 18 checks show a warning or a red flag.

What does Aura Biosciences, Inc. do?

Aura Biosciences, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as AURA.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis